Inactivated Vaccines Market: Future Demand and Top Key Players Analysis | 2029

 Designed to support strategic planning, this report breaks down key metrics and trends across the inactivated vaccines sector.



How Much Is The Inactivated Vaccines Market Worth?
The inactivated vaccines market size has grown steadily in recent years. It will grow from $6.19 billion in 2024 to $6.37 billion in 2025 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to polio eradication efforts, influenza vaccination programs, emerging infectious diseases, regulatory approvals.

The inactivated vaccines market size is expected to see steady growth in the next few years. It will grow to $7.58 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine coverage, biomanufacturing advancements, health equity initiatives. Major trends in the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, digital vaccine passports.

Get your free sample today:
Inactivated Vaccines Market 2025, Trends And Growth By 2034 Sample

What Are The Current Leading Growth Drivers For Inactivated Vaccines Market?
The increasing prevalence of infectious diseases is expected to propel the growth of the inactivated vaccine market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from person to person, resulting in a wide range of symptoms and health complications. Tuberculosis is one type of infectious disease. Inactivated vaccines use non-living pathogens to stimulate an immune response, effectively preventing diseases such as polio, hepatitis A and influenza. For instance, in November 2023, according to an article published by Centers for Disease Control and Prevention, a US-based national public health agency, the number of tuberculosis patients in the USA has increased from 8,320 in 2022 to 9,615 in 2023 indicating an iincrease of 1,295 cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the inactivated vaccine market.

Which Segment Accounted For The Largest Inactivated Vaccines Market Share?
The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

Inactivated Vaccines Market Emerging Trends And Opportunities
Major companies operating in the inactivated vaccines market are introducing innovative and advanced inactivated vaccines to sustain their position in the market. An inactivated vaccine contains inactivated virus particles, bacteria, or other pathogens that have been developed in culture and subsequently killed to destroy disease-producing ability. For instance, in January 2022, GSK PLC, a UK-based pharmaceutical and biotechnology company, released a new inactivated vaccination to aid with shingles protection named Shingrix to prevent shingles (Herpes zoster). Shingrix is a non-live, recombinant subunit adjuvanted vaccination administered intramuscularly in two doses. The vaccine's initial indication was for individuals 50 years and older. It has lately been expanded to cover persons 18 and older at a higher risk of developing shingles due to immunodeficiency or immunosuppression caused by a known illness or treatment.

Which Are The Top Companies To Hold The Market Share In Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

View the full inactivated vaccines market report here:
Inactivated Vaccines Market 2025, Trends And Growth By 2034

Which Region Is Projected To Account For The Largest Share Of The Inactivated Vaccines Market?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contact Us:

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Future of the Antifungals Market: Insights, Developments, and Strategic Overview

Image
 Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the antifungals industry. Antifungals Market Valuation Forecast: What Will The Market Be Worth By 2025? The antifungals market size has grown strongly in recent years. It will grow from $27.16 billion in 2024 to $29.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education. The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, ...
Read more

Polybutylene Terephthalate (PBT) Market Analysis 2025 – Supporting High-Stakes Corporate Planning

Image
 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Polybutylene Terephthalate (PBT) industry. What is the projected value of the polybutylene terephthalate (pbt) market by 2029? The polybutylene terephthalate (PBT) market size has grown strongly in recent years. It will grow from $2.5 billion in 2024 to $2.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to adoption in new industries, global economic conditions, electrical vehicle adoption, consumer goods and textile applications, advancements in material properties. The polybutylene terephthalate (PBT) market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued focus on...
Read more

Zero Trust Security Market Report 2025 – Insights for Decision Makers and Market Strategists

Image
 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the zero trust security industry by 2029? The zero trust security market size has grown rapidly in recent years. It will grow from $38.45 billion in 2024 to $45.05 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to cyber threat landscape, legacy security challenges, digital transformation, remote workforce trend, data privacy concerns. The zero trust security market size is expected to see exponential growth in the next few years. It will grow to $99.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to threat intelligence integration, user-centric security approach, data volume growth, business co...
Read more